Dutch study warns that repeated COVID-19 mRNA vaccinations affect immune response in older adults

COVID-19 News: A recent study conducted by researchers at the National Institute for Public Health and the Environment (RIVM) in the Netherlands has shed new light on how repeated COVID-19 mRNA vaccinations affect the immune system of older adults. The study focused on the changes in antibody responses among individuals aged 65 to 83 who received multiple doses of the vaccine. This COVID-19 News report delves into the key findings and explores how the repeated vaccinations may influence immune functions, particularly in older populations.


Dutch study warns that repeated COVID-19 mRNA vaccinations affect immune
response in older adults

The study examines the way repeated mRNA vaccines lead to a class switch in antibodies and the subsequent effects on immune functionality. The study team were particularly interested in the shift in antibody types in older adults and how this could impact vaccine efficacy.
 
Understanding the Immune Response to COVID-19 mRNA Vaccines
Previous research claimed that the COVID-19 mRNA vaccines are highly effective at boosting immunity by stimulating the production of antibodies that target the SARS-CoV-2 spike protein. These antibodies are critical for neutralizing the virus and preventing severe illness. However, as the global vaccine rollout continued, researchers observed that the nature of the antibody response changed with each additional booster dose, particularly in older adults.
 
In the initial doses, the vaccine primarily induces antibodies belonging to the IgG1 and IgG3 subclasses, which are proficient at neutralizing the virus and activating immune cells such as natural killer (NK) cells. These antibodies are vital for eliminating infected cells and preventing the spread of the virus within the body.
 
The IgG4 Class Switch and Its Implications
One of the most intriguing findings from the study is the discovery of a class switch from IgG1 and IgG3 to IgG4 after repeated mRNA vaccinations. This class switching refers to the process by which the immune system produces different types of antibodies, each with unique functions. Researchers observed that after the third vaccination, there was a significant increase in IgG4 antibodies, which are less effective at neutralizing viruses and activating immune cells compared to IgG1 and IgG3. The switch to IgG4 is thought to occur because of prolonged exposure to the spike protein, either through infection or repeated vaccinations.

Unlike IgG1 and IgG3, IgG4 has a unique structural property called Fab-arm exchange, which allows it to bind to two different antigens at once, reducing its ability to form strong complexes and trigger immune responses. This change could have profound implications for how well the immune system responds to future exposures to SARS-CoV-2.
 
Reduced NK Cell Activation and Immune Efficiency
A crucial part of the study focused on the ability of antibodies to activate NK cells, which play a key role in clearing infected cells. The researchers measured NK cell activation in response to the spike protein in blood samples from older adults after their second, third, and fifth vaccine doses. The results showed a clear decrease in NK cell activation as the proportion of IgG4 antibodies increased. This means that as the immune system produces more IgG4 antibodies, its ability to mount a robust response against the virus may be compromised.
 
Additionally, researchers found that the efficiency of the complement system - a crucial part of the immune system responsible for marking pathogens for destruction - also decreased with the rise in IgG4 levels. The complement system relies heavily on IgG1 and IgG3 to function effectively, and the shift to IgG4 could impair its ability to fight infections.
 
Comparing Younger and Older Adults
The study also compared antibody responses between older and younger adults. While both age groups experienced an increase in IgG4 after repeated vaccinations, older adults exhibited a more pronounced shift. This could be due to age-related changes in the immune system, which tend to make older individuals less responsive to vaccines and more susceptible to infections.
 
Researchers noted that younger adults maintained higher levels of IgG1 and IgG3 even after receiving their third dose of the vaccine. This suggests that their immune systems were better able to preserve the types of antibodies that are most effective at neutralizing the virus and activating immune cells.
 
Impact on Vaccine Effectiveness
One of the most important questions arising from this study is whether the increase in IgG4 antibodies will affect the overall effectiveness of the COVID-19 mRNA vaccines. The researchers emphasized that IgG4 antibodies are not inherently harmful; in fact, they play a critical role in regulating the immune system and preventing excessive inflammation. However, the reduced capacity of IgG4 to activate NK cells and the complement system raises concerns about whether repeated vaccinations might diminish the body’s ability to clear the virus efficiently.
 
It’s important to note that the vaccines remain highly effective at preventing severe disease and death, even in older adults who experience this class switch. However, the study's authors suggest that further research is needed to fully understand how the long-term use of mRNA vaccines will influence the immune system, especially in vulnerable populations like the elderly.
 
Conclusions and Future Research
The findings from this study offer valuable insights into the complex dynamics of the immune response to COVID-19 mRNA vaccines. The class switch from IgG1 and IgG3 to IgG4 highlights the adaptability of the immune system, but it also raises important questions about how this shift affects the body's ability to fight off infections. Additional research is needed to explore the mechanisms behind this class switching and to determine whether alternative vaccination strategies might be more effective for older adults.
 
In conclusion, repeated COVID-19 mRNA vaccinations in older adults lead to a significant increase in IgG4 antibodies, which are less effective at activating key immune functions. While the vaccines continue to provide strong protection against severe illness, understanding these shifts in immune response is crucial for optimizing future vaccination strategies, especially for vulnerable populations. This study underscores the need for ongoing research to ensure that booster campaigns remain effective as the pandemic evolves.
 
The study findings were published in the peer-reviewed journal: Immunity & Ageing.
https://link.springer.com/article/10.1186/s12979-024-00466-9
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/covid-19-news-study-shows-mrna-shots-cause-class-switch-toward-noninflammatory,-spike-igg4-antibodies-which-causes-dysfunctional-immunity
 
https://www.thailandmedical.news/news/covid-19-news-igg4-antibodies-produced-by-mrna-shots-generate-immune-tolerance-to-sars-cov-2-s-spike-protein-by-immune-system-suppression
 
https://www.thailandmedical.news/news/breaking-covid-19-news-international-study-finds-that-sars-cov-2-induces-igg4-synthesis-to-evade-the-immune-system